Literature DB >> 19103601

Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086.

Alessandro Mascioni1, Breagh E Bentley, Rosaria Camarda, Deborah A Dilts, Pamela Fink, Viktoria Gusarova, Susan K Hoiseth, Jaison Jacob, Shuo L Lin, Karl Malakian, Lisa K McNeil, Terri Mininni, Franklin Moy, Ellen Murphy, Elena Novikova, Scott Sigethy, Yingxia Wen, Gary W Zlotnick, Désirée H H Tsao.   

Abstract

LP2086 is a family of outer membrane lipoproteins from Neisseria meningitidis, which elicits bactericidal antibodies and are currently undergoing human clinical trials in a bivalent formulation where each antigen represents one of the two known LP2086 subfamilies. Here we report the NMR structure of the recombinant LP2086 variant B01, a representative of the LP2086 subfamily B. The structure reveals a novel fold composed of two domains: a "taco-shaped" N-terminal beta-sheet and a C-terminal beta-barrel connected by a linker. The structure in micellar solution is consistent with a model of LP2086 anchored to the outer membrane bilayer through its lipidated N terminus. A long flexible chain connects the folded part of the protein to the lipid anchor and acts as spacer, making both domains accessible to the host immune system. Antibodies broadly reactive against members from both subfamilies have been mapped to the N terminus. A surface of subfamily-defining residues was identified on one face of the protein, offering an explanation for the induction of subfamily-specific bactericidal antibodies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19103601      PMCID: PMC2659232          DOI: 10.1074/jbc.M808831200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Convergent solutions to binding at a protein-protein interface.

Authors:  W L DeLano; M H Ultsch; A M de Vos; J A Wells
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

Review 2.  Meningococcal disease.

Authors:  N E Rosenstein; B A Perkins; D S Stephens; T Popovic; J M Hughes
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

3.  Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis.

Authors:  Duzhang Zhu; Vicki Barniak; Ying Zhang; Bruce Green; Gary Zlotnick
Journal:  Vaccine       Date:  2006-03-31       Impact factor: 3.641

4.  A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant.

Authors:  A Lex; K H Wiesmüller; G Jung; W G Bessler
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

5.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology.

Authors:  G Cornilescu; F Delaglio; A Bax
Journal:  J Biomol NMR       Date:  1999-03       Impact factor: 2.835

6.  Evaluation of recombinant lipidated P2086 protein as a vaccine candidate for group B Neisseria meningitidis in a murine nasal challenge model.

Authors:  Duzhang Zhu; Ying Zhang; Vicki Barniak; Liesel Bernfield; Alan Howell; Gary Zlotnick
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

8.  Pseudo-structures for the 20 common amino acids for use in studies of protein conformations by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance.

Authors:  K Wüthrich; M Billeter; W Braun
Journal:  J Mol Biol       Date:  1983-10-05       Impact factor: 5.469

9.  Effect of lipopolysaccharide structure on reactivity of antiporin monoclonal antibodies with the bacterial cell surface.

Authors:  A T Bentley; P E Klebba
Journal:  J Bacteriol       Date:  1988-03       Impact factor: 3.490

10.  Vaccine potential of the Neisseria meningitidis 2086 lipoprotein.

Authors:  Leah D Fletcher; Liesel Bernfield; Vicki Barniak; John E Farley; Alan Howell; Melissa Knauf; Peggy Ooi; Robert P Smith; Paige Weise; Mike Wetherell; Xiaoling Xie; Robert Zagursky; Ying Zhang; Gary W Zlotnick
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more
  36 in total

1.  Molecular mechanisms of complement evasion: learning from staphylococci and meningococci.

Authors:  Davide Serruto; Rino Rappuoli; Maria Scarselli; Piet Gros; Jos A G van Strijp
Journal:  Nat Rev Microbiol       Date:  2010-06       Impact factor: 60.633

2.  A meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes.

Authors:  Monica Konar; Rolando Pajon; Peter T Beernink
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

Review 3.  Lipoproteins of bacterial pathogens.

Authors:  A Kovacs-Simon; R W Titball; S L Michell
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

4.  Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086).

Authors:  Laura Cendron; Daniele Veggi; Enrico Girardi; Giuseppe Zanotti
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-04-20

Review 5.  Structural vaccinology starts to deliver.

Authors:  Philip R Dormitzer; Guido Grandi; Rino Rappuoli
Journal:  Nat Rev Microbiol       Date:  2012-12       Impact factor: 60.633

6.  Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen.

Authors:  Enrico Malito; Agnese Faleri; Paola Lo Surdo; Daniele Veggi; Giulietta Maruggi; Eva Grassi; Elena Cartocci; Isabella Bertoldi; Alessia Genovese; Laura Santini; Giacomo Romagnoli; Erica Borgogni; Sébastien Brier; Carla Lo Passo; Maria Domina; Flora Castellino; Franco Felici; Stijn van der Veen; Steven Johnson; Susan M Lea; Christoph M Tang; Mariagrazia Pizza; Silvana Savino; Nathalie Norais; Rino Rappuoli; Matthew J Bottomley; Vega Masignani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-08       Impact factor: 11.205

7.  The Dual Role of Lipids of the Lipoproteins in Trumenba, a Self-Adjuvanting Vaccine Against Meningococcal Meningitis B Disease.

Authors:  Yin Luo; Olga V Friese; Herbert A Runnels; Lakshmi Khandke; Gary Zlotnick; Ann Aulabaugh; Thomas Gore; Eugene Vidunas; Stephen W Raso; Elena Novikova; Emilia Byrne; Michael Schlittler; Donald Stano; Robert L Dufield; Sandeep Kumar; Annaliesa S Anderson; Kathrin U Jansen; Jason C Rouse
Journal:  AAPS J       Date:  2016-09-07       Impact factor: 4.009

8.  Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H binding.

Authors:  Serena Giuntini; Donald C Reason; Dan M Granoff
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

9.  Identifying currents in the gene pool for bacterial populations using an integrative approach.

Authors:  Jing Tang; William P Hanage; Christophe Fraser; Jukka Corander
Journal:  PLoS Comput Biol       Date:  2009-08-07       Impact factor: 4.475

10.  A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups.

Authors:  Peter T Beernink; Carla LoPasso; Antonella Angiolillo; Franco Felici; Dan Granoff
Journal:  Mol Immunol       Date:  2009-03-14       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.